For healthcare professionals only


Oxfam accuses Pfizer of “moral bankruptcy”

BMJ 2001; 323 doi: (Published 28 July 2001) Cite this as: BMJ 2001;323:186
  1. Rory Watson
  1. Brussels

    Pfizer, the world's largest pharmaceutical company, is being accused of moral bankruptcy by pricing lifesaving drugs beyond the reach of millions of people in developing countries.

    The charge comes from the United Kingdom based charity, Oxfam, which is campaigning to end the company's single pricing policy and is pressing for more flexible use of patent rules.

    In a new report released simultaneously in eight countries, Oxfam has claimed that the company has aggressively …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription